beta
OMED
OncoMed Pharmaceuticals Inc.
Chart
Stats
Earnings
News
Splits
Dividends
Earnings
| Actual EPS |
|---|
| Consensus EPS |
| Estimated EPS |
| Number of Estimates |
| EPS Surprise |
Stats
Summary
OncoMed Pharmaceuticals Inc is a clinical development-stage biopharmaceutical company focused on discovering and developing novel anti-cancer stem cell and immuno-oncology product candidates.
Market Cap: 109 Million
Primary Exchange: Nasdaq Global Select
Website: http://www.oncomed.com
Shares Outstanding: 37.9 Million
Float: 37.1 Million
Dividend: 0.0 (0.0%)
Beta: 2.239562
Sector: Healthcare
Industry: Biotechnology
Ethical Flags
Longest drawdown: 1382 trading days
From: 2014-02-25 To: 2019-04-23
Lowest Point:
| Ex-Date | Payment Date | Record Date | Declared Date | Amount | Flag | Dividend Type | Qualified | Indicated |
|---|
| Ex-Date | Declared Date | Record Date | Payment Date | Ratio | To Factor | For Factor |
|---|